Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia

Jorge R. Quesada, James Reuben, John T. Manning, Evan M. Hersh, Jordan U. Gutterman

Research output: Contribution to journalArticlepeer-review

749 Scopus citations

Abstract

We treated seven patients who had progressive hairy-cell leukemia with daily doses of 3 million units of partially pure alpha (leukocyte) interferon by the intramuscular route. Three patients had a complete remission, and four had a partial remission, according to strict criteria for a response. After treatment, bone-marrow aspirates showed an absence of leukemia cells in three patients and 5 per cent or fewer in three others. Normalization of subnormal peripheral-blood values occurred in six of six patients with anemia, in seven of seven with granulocytopenia, and in four of four with thrombocytopenia. Remissions have been maintained for over 6 to over 10 months. Alpha interferon appears to be highly effective in patients with hairy-cell leukemia.

Original languageEnglish (US)
Pages (from-to)15-18
Number of pages4
JournalNew England Journal of Medicine
Volume310
Issue number1
DOIs
StatePublished - Jan 5 1984

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Alpha Interferon for Induction of Remission in Hairy-Cell Leukemia'. Together they form a unique fingerprint.

Cite this